12th Annual DeGregorio Family Foundation Grant Award for Cancers of the Esophagus and Stomach
The DeGregorio Family Foundation for Gastric and Esophageal Cancer is pleased to announce our 12th annual funding opportunity for gastroesophageal malignancies. The Foundation seeks to promote and facilitate collaborative research on the pathogenesis, early diagnosis, and treatment of upper gastrointestinal malignancies. We support high quality, innovative, and transformative translational and bench research to improve the understanding of the biology of these diseases, identification of potential novel therapeutic targets, or in the development and evaluation of novel biomarkers for early diagnosis and treatment. Pre-clinical research, basic mechanistic studies, genomic/epigenomic studies, as well as epidemiologic studies may also be supported
Applications currently under review
Thanks to a generous anonymous donor, this year we are able to support up to two additional grants for gastroesophageal malignancies with the same guidelines as above and the same protocol. These Special Grant Awards have an earlier deadline of July 15, 2021.
Application Timeline and Grant Details - Applications Currently Under Review
Deadline: November 2, 2021. Up to $250,000 over two years will be awarded.
Funding Period: January 15, 2022 – January 14, 2024
Amount: $250,000 for entire grant period. (Indirect costs cannot exceed 10%, and the entire grant cannot exceed $250,000.)
Deadline for applications: Tuesday, Nov. 2, 2021
Eligibility: The Foundation must be associated with an academic or medical institution possessing a tax-exempt status under section 501(c)(3) of the IRS code.
We are not accepting applications from postdocs. Research projects must not be funded currently under a separate mechanism.
Research projects are selected through a rigorous review process, and project goals must align with the DeGregorio Family Foundation’s mission. The Foundation’s application review process is guided by its Scientific Advisory Board. Criteria for successful grants are impact, the likelihood of completion, and making a significant contribution to understanding, diagnosing. or treating gastric or esophageal malignancies. The intention of this award is to provide seed funding for research in upper GI malignancies. Funded applicants are expected to apply for subsequent peer-reviewed support (i.e. NIH or similar agency).
We wish all the applicants luck and we hope to announce winners by mid-January.
Accountability:
Funding will be divided into three installments. The first installment will be provided when appropriate institutional approvals are submitted and the study is underway. The 2nd installment is contingent upon submission and review of an interim report at 1 year, and the final installment will be contingent upon receipt of a final study report.
Any publications or presentations resulting from this research must be acknowledged.
Applications Timeline and Further Details
We owe him a debt of gratitude for our ongoing success.” Lynn DeGregorio, President Founder
The DeGregorio Family for Gastric and Esophageal Cancer (Gastroesophageal Cancer) is pleased to announce its 13th annual funding opportunity for gastroesophageal malignancies in honor of Michael F. Price. The Foundation seeks to promote and facilitate collaborative research on the pathogenesis, early diagnosis and treatment of upper gastrointestinal malignancies. We support high quality, innovative and transformative translational and bench research to improve the understanding of the biology of these diseases, identification of potential novel therapeutic targets, or in the development and evaluation of novel biomarkers for early diagnosis and treatment. Pre-clinical research, basic mechanistic studies, genomic/epigenomic studies as well as epidemiologic studies may also be supported.
Funding: $250,000 over 2 years.
Indirect costs: 10%,
The deadline for applications is November 1, 2022. Funding period: January 15, 2023 – January 14, 2025. Winners announced: mid-January 2023.
Applications Timeline and Further Details
Deadline: Tuesday, November 1, 2022
Funding Period: January 15, 2023 – January 15, 2025
Amount: $250,000 for entire grant period. (Indirect costs cannot exceed 10% and the entire grant cannot not exceed $250,000.)
Eligibility: The Foundation must be associated with an academic or medical institution possessing a tax-exempt status under section 501(c)(3) of the IRS code.
We are not accepting applications from postdocs.
Please do not submit the same grant application to the DeGregorio Family Foundation as from a previous grant cycle unless the Foundation has specifically requested that you do so.
Research projects must not be funded currently under a separate mechanism. Research projects are selected through a rigorous review process. The Foundation’s application review process is guided by its Scientific Advisory Board headed by Dr. Manish A. Shah.
We wish all the applicants luck and we hope to announce winners by mid-January 2022.
Accountability: Funding will be divided into three installments. The first installment will be provided when appropriate institutional approvals are submitted and the study is underway. The 2nd installment is contingent upon submission and review of an interim report at 1 year, the 3rd installment will be contingent upon submission and review of an interim report at 2 years. A final study report must be completed.
Any publications or presentations resulting from this research must be acknowledged.
Any questions should be sent in writing to sarah@degregorio.org and will be answered in an expeditious manner.